Home 
FOR AUTHORS Bratislava Medical Journal 2015 Bratislava Medical Journal Vol.116, No.9, p.533–538, 2015
FOR AUTHORS Bratislava Medical Journal 2015 Bratislava Medical Journal Vol.116, No.9, p.533–538, 2015
Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Ekologia - Ecology Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudba 2025Webshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.116, No.9, p.533–538, 2015 |
||
| Title: The use of antiplatelet medication in hospitalised elderly patients | ||
| Author: M. Wawruch, V. Slezakova, J. Murin, M. Kuzelova, A. Dukat, M. Zabka, T. Leitmann, J. Tisonova, Z. Kallay | ||
| Abstract: BACKGROUND: The use of antiplatelet agents is strongly recommended for the secondary prevention of ischemic events such as myocardial infarction, stroke/transient ischemic attack (TIA). OBJECTIVES: The aim of our study was to analyse the use of antiplatelet medication in patients after myocardial infarction, stroke/TIA, and patients with both conditions and to identify patient-related characteristics, which determine the use of such drugs in elderly patients. METHODS: Study sample (n = 372) was derived from 2,157 patients admitted to long-term care departments of three municipal hospitals. The study included patients aged ≥65 years after myocardial infarction, stroke/TIA or both. RESULTS: Antiplatelet medications were prescribed in 54.8 % and 68.5 % of patients at hospital admission and discharge, respectively. Hospitalisation led to a significant increase in the use of antiplatelet medication in patients after myocardial infarction and in those with the combination of both events. However, in patients after only stroke/TIA, we did not find any significant difference comparing the use of antiplatelet medication at the time of hospital admission and discharge, respectively. CONCLUSION: Our study revealed that physicians are more aware of the benefits of antiplatelet medication in elderly patients after myocardial infarction or those after both myocardial infarction and stroke/TIA in comparison with patients after only stroke/TIA (Tab. 3, Ref. 32). |
||
| Keywords: myocardial infarction, cerebrovascular, stroke, transient ischemic attack, bleeding risk, thrombotic event. | ||
| Published online: 24-Sep-2015 | ||
| Year: 2015, Volume: 116, Issue: 9 | Page From: 533, Page To: 538 | |
| doi:10.4149/BLL_2015_102 |
||
|
|
 download file |
|